| Chr | chr10 |
| start | 6737382 |
| end | 6739026 |
| lncRNA name | LINP1 |
| entrez id | 108570035 |
| hgnc id | HGNC:53170 |
| ensg id | ENSG00000223784 |
| refseq id | NR_138480 |
| methods | qPCR, Western blot |
| regulated | up-regulated |
| function description | LINP1 knockdown mitigated breast cancer cell growth by inducing G1-phase cell cycle arrest and apoptosis. LINP1 also promoted breast cancer cell metastasis and influenced the expression of epithelial-mesenchymal transition-related markers. We identified p53 as a regulator of LINP1, and LINP1 overexpression could restore the metastatic effects of p53. Furthermore, LINP1 was upregulated in doxorubicin- and 5-fluorouracil-resistant cells and induced chemoresistance. We also observed that LINP1 enrichment played a critical functional role in chemoresistance by inhibiting chemotherapeutics-induced apoptosis. Moreover, LINP1 in tumors was associated with lower overall survival and disease-free survival. |
| pubmed id | 29293402 |
| year | 2018 |
| title | Long noncoding RNA LINP1 acts as an oncogene and promotes chemoresistance in breast cancer. |
| drug | X |
| circulating | X |
| survival | V |
CopyRight © University of Miami, USA; Harbin Medical University, China